SIRION Biotech Announces Collaboration with Sanofi to Innovate Gene Therapy Treatments with Improved Adeno-Associated Virus Capsids
Joining forces to develop gene therapies for multiple life-threatening disorders
MUNICH, Germany,...
Newsroom
SIRION Biotech licenses its LentiBOOST® transduction technology to Cellectis
Munich, Germany and Cambridge, Mass., January 7, 2021–Through this license agreement, SIRION...
Mustang Bio licenses LentiBOOST™ Technology from SIRION Biotech for the development of MB-207 lentiviral gene therapy
| Source:Mustang Bio, Inc.,globenewswire.com
WORCESTER, Mass. and...
Orchard Therapeutics and SIRION Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency
BOSTON and LONDON and MARTINSRIED, Germany, Dec. 14, 2018 (GLOBE NEWSWIRE) — Orchard Therapeutics...
Subscribe Here!
Contact Us
Whether you seek help customizing a vector for academic use or support for your industrial R&D, we will assist you from square one to discuss and plan your project in detail.
